Correlation Between Kulicke and CureVac NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kulicke and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kulicke and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kulicke and Soffa and CureVac NV, you can compare the effects of market volatilities on Kulicke and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kulicke with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kulicke and CureVac NV.

Diversification Opportunities for Kulicke and CureVac NV

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Kulicke and CureVac is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Kulicke and Soffa and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Kulicke is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kulicke and Soffa are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Kulicke i.e., Kulicke and CureVac NV go up and down completely randomly.

Pair Corralation between Kulicke and CureVac NV

Given the investment horizon of 90 days Kulicke and Soffa is expected to generate 0.52 times more return on investment than CureVac NV. However, Kulicke and Soffa is 1.92 times less risky than CureVac NV. It trades about 0.01 of its potential returns per unit of risk. CureVac NV is currently generating about -0.02 per unit of risk. If you would invest  4,837  in Kulicke and Soffa on October 11, 2024 and sell it today you would lose (83.00) from holding Kulicke and Soffa or give up 1.72% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kulicke and Soffa  vs.  CureVac NV

 Performance 
       Timeline  
Kulicke and Soffa 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kulicke and Soffa are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain forward indicators, Kulicke may actually be approaching a critical reversion point that can send shares even higher in February 2025.
CureVac NV 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CureVac NV are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting basic indicators, CureVac NV exhibited solid returns over the last few months and may actually be approaching a breakup point.

Kulicke and CureVac NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kulicke and CureVac NV

The main advantage of trading using opposite Kulicke and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kulicke position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.
The idea behind Kulicke and Soffa and CureVac NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stocks Directory
Find actively traded stocks across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings